Evidence map›Paper›PMID 34037521›Full record

RevieweLife2021

Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling.

Johannes Trück, Anne Eugster, Pierre Barennes, Christopher M Tipton, Eline T Luning Prak, Davide Bagnara, Cinque Soto, Jacob S Sherkow, Aimee S Payne, Marie-Paule Lefranc and 4 more

Abstract readReview
In one paragraph

Review in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. AI-Driven BCR Modeling for Precision Immunology.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Challenges and future directions of AIRR-seq-based diagnostics.Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
  5. The BCR-SEQC initiative.Nature immunology · 2025
    Article
  6. Review
  7. B cell tolerance and autoimmunity: Lessons from repertoires.The Journal of experimental medicine · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases.Clinical reviews in allergy & immunology · 2024
    Review
  13. Article
  14. CD27 on human memory B cells-more than just a surface marker.Clinical and experimental immunology · 2023
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Johannes Trück *University Children's Hospital and the Children's Research Center, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-0418-7381
Anne Eugster *CRTD Center for Regenerative Therapies Dresden, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0001-8009-5959
Pierre Barennes *Sorbonne Université U959, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.
Christopher M TiptonLowance Center for Human Immunology, Emory University School of Medicine, Atlanta, United States.
Eline T Luning PrakPerelman School of Medicine, University of Pennsylvania, Philadelphia, United States.ORCID 0000-0002-9478-9211
Davide BagnaraUniversity of Genoa, Department of Experimental Medicine, Genoa, Italy.
Cinque SotoThe Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, United States.ORCID 0000-0002-3997-6217
Jacob S SherkowCollege of Law, University of Illinois, Champaign, United States.ORCID 0000-0002-9724-9261
Aimee S PaynePerelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Marie-Paule LefrancIMGT, The International ImMunoGeneTics Information System (IMGT), Laboratoire d'ImmunoGénétique Moléculaire (LIGM), Institut de Génétique Humaine (IGH), CNRS, University of Montpellier, Montpellier, France.ORCID 0000-0003-0116-9353
Andrew FarmerTakara Bio USA, Inc., Mountain View, United States.
AIRR Community
Magnolia Bostick *Takara Bio USA, Inc., Mountain View, United States.
Encarnita Mariotti-Ferrandiz *Sorbonne Université U959, Immunology-Immunopathology-Immunotherapy (i3), Paris, France.ORCID 0000-0002-8770-0186

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3M
Transcriptomics and Repertoire ProfilingP01AI106697 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Donna L. Farber · 2013 to 2026
$31.3M
Penn integrated Human Pancreas procurement and Analysis ProgramUC4DK112217 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI BETTS, MICHAEL R, FELDMAN, MICHAEL D · 2016 to 2020
$17.8M
University of Pennsylvania Clinical Autoimmunity Center of ExcellenceUM1AI144288 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BAR-OR, AMIT, PAYNE, AIMEE S · 2019 to 2023
$551k
NCI NIH HHS P30 CA016520NIAID NIH HHS P01 AI106697NIAID NIH HHS UM1 AI144288NIDDK NIH HHS UC4 DK112217
6 · The paper itself

Abstract

Use of adaptive immune receptor repertoire sequencing (AIRR-seq) has become widespread, providing new insights into the immune system with potential broad clinical and diagnostic applications. However, like many high-throughput technologies, it comes with several problems, and the AIRR Community was established to understand and help solve them. We, the AIRR Community's Biological Resources Working Group, have surveyed scientists about the need for standards and controls in generating and annotating AIRR-seq data. Here, we review the current status of AIRR-seq, provide the results of our survey, and based on them, offer recommendations for developing AIRR-seq standards and controls, including future work.

Indexed as

TranscriptomeAdaptive ImmunityAnimalsDatabases, GeneticGene Expression ProfilingHumansObserver VariationQuality ControlReceptors, ImmunologicReference StandardsReproducibility of ResultsRNA-SeqReceptors, ImmunologicantibodyB-cell Receptor (BCR)IGimmunoglobulinimmunologyinflammationnext generation sequencing (NGS)T-cell Receptor (TCR)TR

Identifiers

PMID34037521
PMCPMC8154019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.